---
title: "ZVRA.US (ZVRA.US) — 相關新聞"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/ZVRA.US/news.md"
symbol: "ZVRA.US"
name: "ZVRA.US"
parent: "https://longbridge.com/zh-HK/quote/ZVRA.US.md"
datetime: "2026-03-15T21:27:07.988Z"
locales:
  - [en](https://longbridge.com/en/quote/ZVRA.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ZVRA.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ZVRA.US/news.md)
---

> 支持的語言: [English](https://longbridge.com/en/quote/ZVRA.US/news.md) | [简体中文](https://longbridge.com/zh-CN/quote/ZVRA.US/news.md)


# ZVRA.US (ZVRA.US) — 相關新聞

### [Zevra Therapeutics Faces Partnership Hurdles That Could Delay Drug Development and Pressure Financing](https://longbridge.com/zh-HK/news/278664257.md)
*2026-03-11T06:00:40.000Z*
> Zevra Therapeutics Faces Partnership Hurdles That Could Delay Drug Development and Pressure Financing

### [Why Zevra Therapeutics Stock Zoomed 21% Higher Today](https://longbridge.com/zh-HK/news/278622750.md)
*2026-03-10T22:25:17.000Z*
> Zevra Therapeutics (NASDAQ: ZVRA) saw its stock surge over 21% following a strong earnings report, which revealed a 44% 

### [Top 10 US Stock Gainers (3.10)](https://longbridge.com/zh-HK/news/278620756.md)
*2026-03-10T22:00:53.000Z*
> Figure Tech Solutions - CL(FIGR) rose 21.29%, with a trading turnover 1.1 Billion USD, and a year-to-date fell 3.1%. Zev

### [Zevra Therapeutics Stock Gains 19% Over Partnership With GeneDx For New Genetic Testing Program](https://longbridge.com/zh-HK/news/278581807.md)
*2026-03-10T15:27:23.000Z*
> Zevra Therapeutics, Inc. (ZVRA) stock surged approximately 19% following GeneDx's announcement of a new genetic testing 

### [](https://longbridge.com/zh-HK/news/278574392.md)
*2026-03-10T14:09:19.000Z*
> Zevra Therapeutics shares are trading higher after the company reported better-than-expected Q4 financial results. Also,

### [12 Health Care Stocks Moving In Tuesday's Pre-Market Session](https://longbridge.com/zh-HK/news/278555488.md)
*2026-03-10T12:06:01.000Z*
> In Tuesday's pre-market session, Catheter Precision (VTAK) shares surged 69.3% to $2.32, while MiNK Therapeutics (INKT) 

### [Why Zevra Therapeutics Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket](https://longbridge.com/zh-HK/news/278526575.md)
*2026-03-10T08:42:17.000Z*
> Zevra Therapeutics shares surged over 17% in pre-market trading after reporting better-than-expected Q4 results, with ea

### [Zevra Turns Profitable In 2025 On Strong Uptake Of MIPLYFFA For Niemann-Pick Disease Type C](https://longbridge.com/zh-HK/news/278515205.md)
*2026-03-10T08:15:16.000Z*
> Zevra Therapeutics, Inc. (ZVRA) reported a profitable 2025, driven by strong sales of its rare disease therapy MIPLYFFA 

### [12 Health Care Stocks Moving In Monday's Pre-Market Session](https://longbridge.com/zh-HK/news/278390342.md)
*2026-03-09T12:05:42.000Z*
> In Monday's pre-market session, several health care stocks saw significant movement. Relmada Therapeutics (RLMD) surged